ISSN (Online): 3107-622X
New Era Medical Journal Logo

New Era Medical Journal

Official Journal of the Society of Multidisciplinary Health Sciences

Open Access Journal

Review Article

Effectiveness of Bifocal and Progressive Addition Spectacle Lenses in Controlling Myopia Progression in Children

Authors: Saad Ahmad, Nida Parveen, Dr. Partha Chowdhury, Dr Brinda Shah

Article Metrics
229
Views
62
Downloads
Altmetric

Abstract

Background: Childhood myopia is increasing globally due to lifestyle factors such as prolonged near work and reduced outdoor activity. Bifocal and progressive addition lenses (PALs) are commonly used optical strategies to control myopia progression, but their effectiveness remains debated.

Objective: To evaluate the effectiveness of bifocal and progressive addition spectacle lenses in slowing myopia progression and axial elongation in children.

Methods: A systematic review and meta-analysis were conducted following PRISMA guidelines. Major databases including PubMed, Scopus, Web of Science, and Cochrane Central were searched up to December 2025. Randomized controlled trials and longitudinal studies involving myopic children aged 5–16 years were included. Outcomes assessed were annual changes in spherical equivalent refraction (SER) and axial length. A random-effects model was used for pooled analysis.

Results: Fourteen studies involving 3,842 children were included. Bifocal and PALs significantly reduced myopia progression by −0.29 D/year (95% CI: −0.38 to −0.20; p < 0.001) and axial elongation by −0.12 mm/year (95% CI: −0.17 to −0.07; p < 0.001). PALs showed slightly greater efficacy than bifocal lenses. Greater benefits were observed in children with high accommodative lag and younger age.

Conclusion: Bifocal and PALs provide a modest but significant reduction in myopia progression and remain a safe, accessible option in pediatric myopia management.

Keywords: Myopia, Children, Bifocal lenses, Progressive addition lenses


Article Information
DOI: 10.62502/nemj/v2i1art1
Journal: New Era Medical Journal
Abbreviation: New Era Med. J.
ISSN (Online): 3107-622X
Volume/Issue: 2(1)
Pages: 1-7

References
  1. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–42.
  2. Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012;379(9827):1739–48.
  3. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622– 60.
  4. Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt. 2005;25(5):381–91.
  5. Smith EL. Optical treatment strategies to slow myopia progression: effects of the visual extent of the optical treatment zone. Exp Eye Res. 2013;114:77–88.
  6. Mutti DO, Hayes JR, Mitchell GL, Jones LA, Moeschberger ML, Cotter SA, et al. Refractive error, axial length, and relative peripheral refractive error before and after onset of myopia. Invest Ophthalmol Vis Sci. 2007;48(6):2510–9.
  7. Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, et al. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci. 2003;44(4):1492–500.
  8. Hyman L, Gwiazda J, Marsh-Tootle WL, Norton TT, Hussein M. The Correction of Myopia Evaluation Trial (COMET): design and baseline characteristics. Control Clin Trials. 2001;22(5):573–92.
  9. Gwiazda J, Hyman L, Norton TT, Hussein M, Marsh-Tootle W, Manny R, et al. Accommodation and related risk factors associated with myopia progression. Invest Ophthalmol Vis Sci. 2004;45(7):2143–51.
  10. Gwiazda J, Hyman L, Dong LM, Everett D, Norton TT, Kurtz D, et al. Factors associated with high myopia in COMET cohort. Ophthalmic Epidemiol. 2007;14(4):230–7.
  11. COMET Group. Myopia stabilization and associated factors among participants in COMET. Invest Ophthalmol Vis Sci. 2013;54(13):7871–84.
  12. Hou W, Norton TT, Hyman L, Gwiazda J. Axial elongation and its association with myopia progression. Eye Contact Lens. 2018;44(4):248– 59.
  13. Scheiman M, Gwiazda J, Zhang Q, Deng L, Manny R, Weissberg E, et al. Longitudinal changes in corneal curvature in COMET. J Optom. 2016;9(1):13–21.
  14. Gwiazda J, Deng L, Manny R, Norton TT. Seasonal variations in myopia progression. Invest Ophthalmol Vis Sci. 2014;55(2):752–8.
  15. Hyman L, Gwiazda J. Lessons from the COMET study. Ann Acad Med Singap. 2004;33(1):44–8.
  16. Walline JJ, Greiner KL, McVey ME, JonesJordan LA. Multifocal contact lens myopia control. Optom Vis Sci. 2013;90(11):1207–14.
  17. Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year randomized clinical trial of myopia control lenses. Optom Vis Sci. 2019;96(8):556–67.
  18. Lam CS, Tang WC, Tse DY, Tang YY, To CH. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression. Br J Ophthalmol. 2020;104(3):363–8.
  19. Sankaridurg P, Holden B, Smith E, Naduvilath T, Chen X, de la Jara PL, et al. Decreasing peripheral hyperopia with contact lenses. Invest Ophthalmol Vis Sci. 2011;52(13):9362–7.
  20. Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et al. Atropine for treatment of myopia in children (ATOM2). Ophthalmology. 2012;119(2):347–54.
  21. Yam JC, Jiang Y, Tang SM, Law AK, Chan JJ, Wong E, et al. Low-concentration atropine for myopia progression (LAMP study). Ophthalmology. 2019;126(1):113–24.
  22. Cho P, Cheung SW. Retardation of myopia in orthokeratology. Invest Ophthalmol Vis Sci. 2012;53(11):7077–85.
  23. He M, Xiang F, Zeng Y, Mai J, Chen Q, Zhang J, et al. Effect of time outdoors on myopia prevention. JAMA. 2015;314(11):1142–8.
  24. Rose KA, Morgan IG, Ip J, Kifley A, Huynh S, Smith W, et al. Outdoor activity reduces myopia prevalence. Ophthalmology. 2008;115(8):1279– 85.
  25. Jones LA, Sinnott LT, Mutti DO, Mitchell GL, Moeschberger ML, Zadnik K. Parental history and myopia development. Invest Ophthalmol Vis Sci. 2007;48(8):3524–32.
  26. Zadnik K, Satariano WA, Mutti DO, Sholtz RI, Adams AJ. The effect of parental history of myopia. Invest Ophthalmol Vis Sci. 1994;35(3):1179–86.
  27. Mutti DO, Mitchell GL, Moeschberger ML, Jones LA, Zadnik K. Parental myopia and axial growth. Invest Ophthalmol Vis Sci. 2002;43(2):363–9.
  28. Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H, et al. Efficacy comparison of myopia control methods. Ophthalmology. 2016;123(4):697–708.
  29. Li SM, Kang MT, Peng XX, Li SY, Wang YP, Li L, et al. Efficacy of spectacle lenses in controlling myopia progression. PLoS One. 2016;11(3):e0149246.
  30. Wu PC, Tsai CL, Wu HL, Yang YH, Kuo HK. Outdoor activity and myopia progression in children. Ophthalmology. 2013;120(5):1080–5.
How to Cite
Vancouver Style:
Ahmad S, Parveen N, Chowdhury DP, Shah DB. Effectiveness of Bifocal and Progressive Addition Spectacle Lenses in Controlling Myopia Progression in Children. New Era Med. J. 2026;2(1):1-7. doi: 10.62502/nemj/v2i1art1